AbbVie 2012 Annual Report Download - page 43

Download and view the complete annual report

Please find page 43 of the 2012 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 200

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200

PART II
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Principal Market
The principal market for AbbVie’s common stock is the New York Stock Exchange. A
‘‘when-issued’’ trading market for AbbVie’s common stock began on the NYSE on December 10, 2012,
and ‘‘regular way’’ trading of AbbVie’s common stock began on January 2, 2013. Prior to December 10,
2012 there was no public market for AbbVie’s common stock. AbbVie’s common stock is also listed on
the Chicago Stock Exchange and traded on various regional and electronic exchanges. Outside the
United States, AbbVie’s common stock is listed on NYSE Euronext Paris and the SIX Swiss Exchange.
From January 2, 2013 through January 31, 2013, the highest sales price for AbbVie’s common
stock on the NYSE was $38.52 per share, and the lowest sales price for AbbVie’s common stock on the
NYSE was $33.33 per share.
Shareholders
There were 60,713 shareholders of record of AbbVie common stock as of January 31, 2013.
Dividends
AbbVie expects that it will pay a regular cash dividend at an annual rate of $1.60 per share,
starting with the quarterly dividend paid in February 2013. However, the timing, declaration, amount
of, and payment of any dividends by AbbVie is within the discretion of its board of directors and will
depend upon many factors, including AbbVie’s financial condition, earnings, capital requirements of its
operating subsidiaries, covenants associated with certain of AbbVie’s debt service obligations, legal
requirements, regulatory constraints, industry practice, ability to access capital markets, and other
factors deemed relevant by its board of directors. Moreover, if AbbVie determines to pay any dividend
in the future, there can be no assurance that it will continue to pay such dividends or the amount of
such dividends.
AbbVie Inc. is an Illinois High Impact Business (HIB) and is located in a federal Foreign Trade
Sub-Zone (Sub-Zone 22S). Dividends may be eligible for a subtraction from base income for Illinois
income tax purposes. If you have questions, please contact your tax advisor.
37